Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Diabetes

PUBLISHER: Grand View Research | PRODUCT CODE: 1790326

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1790326

Pediatric Diabetes Management Market Size, Share & Trends Analysis Report By Product (Insulin Pump, Insulin Pen), By Technology (Connected, Non-Connected), By End Use (Homecare, Pediatric Clinics), By Region, And Segment Forecasts, 2025 - 2033

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Pediatric Diabetes Market Summary

The global pediatric diabetes management market size was estimated at USD 5.59 billion in 2024 and is projected to reach USD 13.11 billion by 2033, growing at a CAGR of 9.96% from 2025 to 2033. The growth of the market is attributed to the rising global prevalence of diabetes, particularly Type 1, among children and adolescents, which has significantly increased the demand for effective monitoring and treatment solutions.

Technological advancements in blood glucose monitoring (BGM), continuous glucose monitoring (CGM), and insulin delivery systems have improved accuracy, convenience, and compliance, making them more suitable for pediatric use. Globally, type 1 diabetes remains the most common form in children, but the rising incidence of childhood obesity, sedentary lifestyles, and poor dietary habits has led to a significant rise in type 2 diabetes diagnoses in younger age groups. According to the International Diabetes Federation, around 1.52 million people aged 20 years had diabetes in 2022. This high prevalence of diabetes is increasing demand for constant monitoring and long-term disease management, thereby contributing to demand for pediatric-focused diabetes care solutions. The increasing regulatory support and initiatives to address diabetes in pediatric patient groups further fuel the market growth.

Technological advancements in diabetes management devices have significantly influenced the market growth as comfort, usability, and real-time insights are crucial for disease adherence. Companies are increasingly investing in the development of compact, minimally invasive, and user-friendly devices that cater specifically to children and adolescents. Innovations such as tubeless insulin pumps, continuous glucose monitors (CGMs) with extended sensor life, and smartphone-connected systems have improved patient compliance and parental monitoring. These devices reduce the burden on both children and caregivers by automating insulin dosing and generating predictive alerts, minimizing the risks of hypoglycemia or hyperglycemia.

Additionally, market players are focusing on launching pediatric-specific design features, such as miniaturization of products, further contributing to their increasing adoption. For instance, in July 2023, Tandem Diabetes Care's miniature-sized insulin pump, Tandem Mobi, controllable via iPhone app and compatible with CGM, got FDA clearance for children (>=6 years) and adults. Half the size of t : slim X2, it integrates Control IQ automation, features shorter tubing, and remote updates.

Global Pediatric Diabetes Management Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pediatric diabetes management market report on the basis of product, technology, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Blood Glucose Monitors (BGM)
  • Continuous Glucose Monitors (CGM)
  • Insulin Pumps
  • Insulin Pens
  • Insulin Syringes
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Connected Devices
  • Non-connected Devices
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
    • General Hospitals
    • Children Hospitals
  • Homecare
  • Pediatric Clinics
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Kuwait
    • UAE
Show more
Product Code: GVR-4-68040-651-8

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Purchased database.
  • 1.5. GVR's internal database
  • 1.6. Secondary sources
  • 1.7. Third Party Perspective
  • 1.8. Primary research
  • 1.9. Details of primary research
  • 1.10. Information or Data Analysis
  • 1.11. Data analysis models
  • 1.12. Market Formulation & Validation
  • 1.13. Model Details
  • 1.14. Commodity flow analysis (Model 1)
  • 1.15. Approach 1: Commodity flow approach
  • 1.16. Volume price analysis (Model 2)
  • 1.17. Approach 2: Volume price analysis
  • 1.18. List of Secondary Sources
  • 1.19. List of Primary Sources
  • 1.20. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Pediatric Diabetes Management Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising incidence of diabetes in children and adolescents
      • 3.2.1.2. Technological advancements in diabetes management devices
      • 3.2.1.3. Increasing awareness and early diagnosis
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of certain diabetes management devices
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Rising preference toward advanced diabetes management devices
    • 3.2.4. Market Challenges Analysis
      • 3.2.4.1. Caregiver burden and patient education challenges
  • 3.3. Pediatric Diabetes Management Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Pediatric Diabetes Management Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Pediatric Diabetes Management Market: Product Movement Analysis & Market Share, 2024 & 2033
  • 4.3. Blood Glucose Monitors (BGM)
    • 4.3.1. Blood Glucose Monitors (BGM) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Continuous Glucose Monitors (CGM)
    • 4.4.1. Continuous Glucose Monitors (CGM) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Insulin Pumps
    • 4.5.1. Insulin Pumps Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Insulin Pens
    • 4.6.1. Insulin Pens Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Insulin Syringes
    • 4.7.1. Insulin Syringes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Pediatric Diabetes Management Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Pediatric Diabetes Management Market: Technology Movement Analysis & Market Share, 2024 & 2033
  • 5.3. Connected Devices
    • 5.3.1. Connected Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Non-connected Devices
    • 5.4.1. Non-connected Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Pediatric Diabetes Management Market: End-use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Pediatric Diabetes Management Market: End-use Movement Analysis & Market Share, 2024 & 2033
  • 6.3. Hospitals
    • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. General Hospitals
      • 6.3.2.1. General Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Children Hospitals
      • 6.3.3.1. Children Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Homecare
    • 6.4.1. Homecare Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Pediatric Clinics
    • 6.5.1. Pediatric Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Pediatric Diabetes Management Market: Regional Estimates & Trend Analysis by Product, Technology, End-Use

  • 7.1. Regional Outlook
  • 7.2. Pediatric Diabetes Management Market: Regional Movement Analysis & Market Share, 2024 & 2033
  • 7.3. North America
    • 7.3.1. North America Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Scenario
      • 7.3.2.4. Reimbursement Scenario
      • 7.3.2.5. U.S. Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Scenario
      • 7.3.3.4. Reimbursement Scenario
      • 7.3.3.5. Canada Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Scenario
      • 7.3.4.4. Reimbursement Scenario
      • 7.3.4.5. Mexico Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Scenario
      • 7.4.2.4. Reimbursement Scenario
      • 7.4.2.5. UK Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Scenario
      • 7.4.3.4. Reimbursement Scenario
      • 7.4.3.5. Germany Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Scenario
      • 7.4.4.4. Reimbursement Scenario
      • 7.4.4.5. France Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Scenario
      • 7.4.5.4. Reimbursement Scenario
      • 7.4.5.5. Italy Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Scenario
      • 7.4.6.4. Reimbursement Scenario
      • 7.4.6.5. Spain Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Scenario
      • 7.4.7.4. Reimbursement Scenario
      • 7.4.7.5. Denmark Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Scenario
      • 7.4.8.4. Reimbursement Scenario
      • 7.4.8.5. Sweden Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Scenario
      • 7.4.9.4. Reimbursement Scenario
      • 7.4.9.5. Norway Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Scenario
      • 7.5.2.4. Reimbursement Scenario
      • 7.5.2.5. Japan Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Scenario
      • 7.5.3.4. Reimbursement Scenario
      • 7.5.3.5. China Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Scenario
      • 7.5.4.4. Reimbursement Scenario
      • 7.5.4.5. India Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Scenario
      • 7.5.5.4. Reimbursement Scenario
      • 7.5.5.5. South Korea Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Australia
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Scenario
      • 7.5.6.4. Reimbursement Scenario
      • 7.5.6.5. Australia Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. Thailand
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Scenario
      • 7.5.7.4. Reimbursement Scenario
      • 7.5.7.5. Thailand Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Scenario
      • 7.6.2.4. Reimbursement Scenario
      • 7.6.2.5. Brazil Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Scenario
      • 7.6.3.4. Reimbursement Scenario
      • 7.6.3.5. Argentina Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Middle East & Africa
    • 7.7.1. Middle East & Africa Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Scenario
      • 7.7.2.4. Reimbursement Scenario
      • 7.7.2.5. South Africa Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Saudi Arabia
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Scenario
      • 7.7.3.4. Reimbursement Scenario
      • 7.7.3.5. Saudi Arabia Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. UAE
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Scenario
      • 7.7.4.4. Reimbursement Scenario
      • 7.7.4.5. UAE Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Scenario
      • 7.7.5.4. Reimbursement Scenario
      • 7.7.5.5. Kuwait Pediatric Diabetes Management Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Medtronic
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Product Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. Dexcom
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Product Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. Abbott
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Product Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. Tandem Diabetes Care
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Product Benchmarking
      • 8.2.4.4. Strategic Initiatives
    • 8.2.5. Insulet Corporation
      • 8.2.5.1. Company Overview
      • 8.2.5.2. Financial Performance
      • 8.2.5.3. Product Benchmarking
      • 8.2.5.4. Strategic Initiatives
    • 8.2.6. Novo Nordisk
      • 8.2.6.1. Company Overview
      • 8.2.6.2. Financial Performance
      • 8.2.6.3. Product Benchmarking
      • 8.2.6.4. Strategic Initiatives
    • 8.2.7. Sanofi
      • 8.2.7.1. Company Overview
      • 8.2.7.2. Financial Performance
      • 8.2.7.3. Product Benchmarking
      • 8.2.7.4. Strategic Initiatives
    • 8.2.8. Eli Lilly and Company
      • 8.2.8.1. Company Overview
      • 8.2.8.2. Financial Performance
      • 8.2.8.3. Product Benchmarking
      • 8.2.8.4. Strategic Initiatives
    • 8.2.9. Roche Diabetes Care
      • 8.2.9.1. Company Overview
      • 8.2.9.2. Financial Performance
      • 8.2.9.3. Product Benchmarking
      • 8.2.9.4. Strategic Initiatives
    • 8.2.10. Ascensia Diabetes Care
      • 8.2.10.1. Company Overview
      • 8.2.10.2. Financial Performance
      • 8.2.10.3. Product Benchmarking
      • 8.2.10.4. Strategic Initiatives
Show more
Product Code: GVR-4-68040-651-8

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global pediatric diabetes management market, by region, 2021 - 2033 (USD Million)
  • Table 3 Global pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 4 Global pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 5 Global pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 6 North America pediatric diabetes management market, by country, 2021 - 2033 (USD Million)
  • Table 7 North America pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 8 North America pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 9 North America pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 10 U.S. pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 11 U.S. pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 12 U.S. pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 13 Canada pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 14 Canada pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 15 Canada pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 16 Mexico pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 17 Mexico pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 18 Mexico pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 19 Europe pediatric diabetes management market, by country, 2021 - 2033 (USD Million)
  • Table 20 Europe pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 21 Europe pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 22 Europe pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 23 UK pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 24 UK pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 25 UK pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 26 Germany pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 27 Germany pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 28 Germany pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 29 France pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 30 France pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 31 France pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 32 Italy pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 33 Italy pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 34 Italy pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 35 Spain pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 36 Spain pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 37 Spain pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 38 Denmark pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 39 Denmark pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 40 Denmark pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 41 Sweden pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 42 Sweden pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 43 Sweden pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 44 Norway pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 45 Norway pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 46 Norway pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific pediatric diabetes management market, by country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 51 China pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 52 China pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 53 China pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 54 Japan pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 55 Japan pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 56 Japan pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 57 India pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 58 India pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 59 India pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 60 South Korea pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 61 South Korea pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 62 South Korea pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 63 Australia pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 64 Australia pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 65 Australia pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 66 Thailand pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 67 Thailand pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 68 Thailand pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 69 Latin America pediatric diabetes management market, by country, 2021 - 2033 (USD Million)
  • Table 70 Latin America pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 71 Latin America pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 72 Latin America pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 73 Brazil pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 74 Brazil pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 75 Brazil pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 76 Argentina pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 77 Argentina pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 78 Argentina pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 79 MEA pediatric diabetes management market, by country, 2021 - 2033 (USD Million)
  • Table 80 MEA pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 81 MEA pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 82 MEA pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 83 South Africa pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 84 South Africa pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 85 South Africa pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 89 UAE pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 90 UAE pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 91 UAE pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)
  • Table 92 Kuwait pediatric diabetes management market, by product, 2021 - 2033 (USD Million)
  • Table 93 Kuwait pediatric diabetes management market, by technology, 2021 - 2033 (USD Million)
  • Table 94 Kuwait pediatric diabetes management market, by end-use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Pediatric diabetes management market segmentation
  • Fig. 3 Market research process
  • Fig. 4 Information procurement process
  • Fig. 5 Primary research pattern
  • Fig. 6 Pediatric diabetes management market snapshot, 2024 (USD Million)
  • Fig. 7 Segment snapshot, USD Million
  • Fig. 8 Competitive landscape snapshot
  • Fig. 9 Penetration & growth prospect mapping
  • Fig. 10 Market driver analysis (Current & future impact)
  • Fig. 11 Market restraint analysis (Current & future impact)
  • Fig. 12 Primary market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 13 Blood glucose monitors market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Continuous glucose monitors market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Insulin pumps market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Insulin pens market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Insulin syringes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Connected devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Non-connected devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 General hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Children hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Homecare market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Pediatric clinics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Pediatric diabetes management market: Regional key takeaways (USD Million)
  • Fig. 26 Pediatric diabetes management market: Regional outlook, 2023 & 2033 (USD Million)
  • Fig. 27 North America pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 U.S. pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Canada pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Mexico pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Europe pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 UK pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Germany pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 France pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Spain pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Italy pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Sweden pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Norway pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Denmark pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Asia Pacific pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 China pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Japan pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 India pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 South Korea pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Australia pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Thailand pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Latin America pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Brazil pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Argentina pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Middle East and Africa pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 South Africa pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Saudi Arabia pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 UAE pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Kuwait pediatric diabetes management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 List of key emerging companies
  • Fig. 56 Company market share analysis, 2024
  • Fig. 57 Market differentiators
  • Fig. 58 Competitive dashboard analysis
  • Fig. 59 Regional network map
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!